27 results
6-K
EX-99.1
BLRX
BioLineRx Ltd.
19 Aug 24
Notice of Annual General Meeting of Shareholders
4:30pm
of whom satisfy the independence requirements of the Nasdaq Listing Rules.
We are not aware of any reason why the nominees, if elected, would be unable
20-F/A
2023 FY
BLRX
BioLineRx Ltd.
26 Mar 24
Annual report (foreign) (amended)
4:57pm
with the director independence requirements and the audit committee and compensation committee composition requirements under U.S. laws (including applicable … directors under the respective “independence” requirements of the SEC and Nasdaq, each of whom is financially literate and one of whom has accounting
6-K
EX-99
BLRX
BioLineRx Ltd.
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
the independence requirements of an independent director as set forth by the Nasdaq Listing Rules and the Securities and Exchange Commission, including … the heightened independence standards to serve on the Company’s Audit Committee and Compensation Committee, and that upon his election
6-K
EX-99
j3lhp
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-1
rjp0 0924
28 May 19
Current report (foreign)
7:04am
20-F/A
6f8wxg755mmivtoqruz
23 Mar 15
Annual report (foreign) (amended)
12:00am
6-K
EX-99
jvexmdltkpo
24 Dec 14
Current report (foreign)
12:00am
424B3
5ddenc
8 Aug 13
Prospectus supplement
12:00am